Clinical Trials Logo

Clinical Trial Summary

Attention deficit disorder in adults with or without hyperactivity (ADHD) is a common disorder, affecting around 3% of the population. ADHD increases the risk of psychiatric disorders (mood disorders, sleep disorders, personality disorders, addictive behavior), risky behaviors, and vocational difficulties. Emotional dysregulation (ED) constitute a major hindrance in the daily life of subjects, with a great impact on the general functioning and the quality of life of the patients.

The investigators want to determine the characteristics of patients with each type of ED (impulsivity, exacerbated emotional intensity, cyclothymia, borderline personality traits), and study the stability of these traits over time. Since circadian rhythms influence mood and circadian rhythms frequently occur in patients with ADHD, the investigators want to determine if there is a link between ED and instability in circadian rhythms. Finally, they would like to observe whether the ED evolves and according to whether or not treatment is taken


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03494478
Study type Interventional
Source University Hospital, Strasbourg, France
Contact Madoé JULIANS, CRA
Phone 03 88 11 61 86
Email madoe.julians@chru-strasbourg.fr
Status Not yet recruiting
Phase N/A
Start date December 2018
Completion date January 2023

See also
  Status Clinical Trial Phase
Completed NCT01939353 - An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder Phase 2
Not yet recruiting NCT03437993 - Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD N/A
Completed NCT01012375 - Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients. Phase 2
Active, not recruiting NCT00318981 - Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD Phase 4